🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,206
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 18,206 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

114 results for “CG” Clear

  1. Campylobacter jejuni strain CG8421

    United Therapeutics Europe Ltd

    Campylobacter Infections

    phase 1 mab active

    1 trial

  2. GSK961081 15mcg SD

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    1 trial

  3. HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  4. ICG-Cisplatin Nanoprobe (NIR-II NanoM)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer, Adult

    phase 1 small molecule active

    1 trial

  5. Nicotine saline infusion 0.00mcg/kg/s

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial

  6. Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer

    Disc Medicine

    Cervical Cancer

    phase 1 other active

    1 trial

  7. Placebo spray and oral moxifloxacin placebo

    Jazz Pharmaceuticals Ireland Limited

    Effects of Sativex on ECG

    phase 1 small molecule completed

    1 trial

  8. TD-4208 175 mcg

    Theravance Biopharma Ireland Umited

    Cardiac Repolarization in Healthy Subjects

    phase 1 small molecule completed

    1 trial

  9. 50 mcg Duramorph+ EXPAREL + multi-modal pain regimen

    Pacira Ireland Limited

    Elective Cesarean Section

    approved small molecule completed

    1 trial

  10. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  11. Buccal Buprenorphine 300 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    Analgesia

    approved small molecule active

    1 trial

  12. CG Future Annuloplasty Ring/Band

    Rhythm Pharmaceuticals Netherlands B.V.

    Mitral Valve Insufficiency

    approved other completed

    1 trial

  13. Engerix-B 20 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved mab completed

    1 trial

  14. RIVAROXABAN , RIVAROXABAN, RIVAROXABAN

    Pari Pharma GmbH

    Patients with excessive supraventricular ectopies or short atrial runs (ESVEA) defined as ≥ 1% premature atrial contractions (PAC) /24 hours or any atrial runs ≥ 20 PACs (but shorter than 30 seconds) on a 24-hour Holter ECG monitoring and CHA2DS2VASC score ≥ 3. Patients with any atrial runs ≥ 20 PACs but shorter than 30 seconds on a 15-21 days Holter ECG monitoring and CHA2DS2VASC score ≥ 3 may also be included in the Short-Run trial.

    approved small molecule active

    1 trial

  15. Rabipur, BCG VACCINE AJV por és oldószer szuszpenziós injekcióhoz BCG vakcina, fagyasztva szárított

    Disc Medicine

    health volunteerst

    approved small molecule active

    1 trial

  16. Tiotropium 'Respimat' 5 mcg

    Universal Integrated

    Chronic Obstructive Airway Disease

    approved small molecule active

    1 trial

  17. BCG

    United Therapeutics Europe Ltd

    Tuberculosis

    mab active

    1 trial

  18. Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.

    Harmony Biosciences Holdings

    Hair Thinning

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,206 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources